CRISPR Therapeutics (CRSP) Oral Presentation of New Data on CTX001 at ASH – StreetInsider.com
The Ledger Gazette |
CRISPR Therapeutics (CRSP) Oral Presentation of New Data on CTX001 at ASH
StreetInsider.com Get instant alerts when news breaks on your stocks. Claim your 2-week free trial to StreetInsider Premium here. CRISPR Therapeutics (NASDAQ: CRSP) today announced that Dr. Bill Lundberg, Chief Scientific Officer of CRISPR, is scheduled to present new … What's Happening To These Stocks? – Vantiv, Inc. (VNTV), CRISPR Therapeutics AG (CRSP) Crispr Therapeutics (CRSP) Rating Lowered to Hold at BidaskClub … The Tyler Dylan-Hyde Sells 21639 Shares of Crispr Therapeutics AG (CRSP) Stock |
